Epigenetic induction of the Ink4a=Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge

1 Instituto de Neurociencias de Alicante UMH-CSIC, San Juan de Alicante 03550, Spain.
Brain (Impact Factor: 9.2). 06/2013; 136(6). DOI: 10.1093/brain/awt130


The number of Schwann cells is fitted to axonal length in peripheral nerves. This relationship is lost when tumorigenic stimuli induce uncontrolled Schwann cell proliferation, generating tumours such us neurofibromas and schwannomas. Schwann cells also re-enter the cell cycle following nerve injury during the process of Wallerian degeneration. In both cases proliferation is finally arrested. We show that in neurofibroma, the induction of Jmjd3 (jumonji domain containing 3, histone lysine demethy-lase) removes trimethyl groups on lysine-27 of histone-H3 and epigenetically activates the Ink4a=Arf-locus, forcing Schwann cells towards replicative senescence. Remarkably, blocking this mechanism allows unrestricted proliferation, inducing malignant transformation of neurofibromas. Interestingly, our data suggest that in injured nerves, Schwann cells epigenetically activate the same locus to switch off proliferation and enter the senescence programme. Indeed, when this pathway is genetically blocked, Schwann cells fail to drop out of the cell cycle and continue to proliferate. We postulate that the Ink4a=Arf-locus is expressed as part of a physiological response that prevents uncontrolled proliferation of the de-differentiated Schwann cell generated during nerve regeneration, a response that is also activated to avoid overproliferation after tumorigenic stimuli in the peripheral nervous system.

Download full-text


Available from: Jose Antonio Gomez-Sanchez, Oct 06, 2015
42 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Located on chromosome 9p21.3, p16(INK4a) seems lost amongst a cluster of neighboring tumor suppressor genes. While best known for inhibiting cyclin dependent kinase (CDK) activity, p16(INK4a) is not a one trick pony. Long term p16(INK4a) expression pushes cells to enter senescence, an irreversible cell cycle arrest that prevents the growth of would-be cancer cells, but also contributes to aging. Loss of p16(INK4a) is one of the most frequent events in human tumors and allows pre-cancerous lesions to bypass senescence. Therefore, precise regulation of p16(INK4a) is essential to tissue homeostasis, maintaining a tight balance between tumor suppression and aging. Here, we outline the pathways required for proper p16(INK4a) regulation and highlight the critical functions of p16(INK4a) in cancer, aging and human physiology that make this gene special.
    Molecular Cancer Research 10/2013; 12(2). DOI:10.1158/1541-7786.MCR-13-0350 · 4.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Our previous findings confirmed that the nerve growth factor-containing fibrin glue membrane provides a good microenvironment for peripheral nerve regeneration; however, the precise mechanism remains unclear. p75 neurotrophin receptor (p75(NTR)) plays an important role in the regulation of peripheral nerve regeneration. We hypothesized that a nerve growth factor-containing fibrin glue membrane can promote neural regeneration by up-regulating p75(NTR) expression. In this study, we used a silicon nerve conduit to bridge a 15 mm-long sciatic nerve defect and injected a mixture of nerve growth factor and fibrin glue at the anastomotic site of the nerve conduit and the sciatic nerve. Through RT-PCR and western blot analysis, nerve growth factor-containing fibrin glue membrane significantly increased p75(NTR) mRNA and protein expression in the Schwann cells at the anastomotic site, in particular at 8 weeks after injection of the nerve growth factor/fibrin glue mixture. These results indicate that nerve growth factor-containing fibrin glue membrane can promote peripheral nerve regeneration by up-regulating p75(NTR) expression in Schwann cells.
    Neural Regeneration Research 12/2013; 8(36):3416-22. DOI:10.3969/j.issn.1673-5374.2013.36.007 · 0.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fate determination of neural crest cells is an essential step for development of different crest cell derivatives. Peripheral glia development is marked by the choice of the neural crest cells to differentiate along glial lineages. The molecular mechanism underlying fate acquisition is poorly understood. However, recent advances have identified different transcription factors and genes required for the complex instructive signaling process that comprise both local environmental and cell intrinsic cues. Among others, at least the role of Sox10, Notch, and neuregulin 1 have been documented in both in vivo and in vitro models. Cooperative interactions of such factors appear to be necessary for the switch from multipotent neural crest cells to glial lineage precursors in the peripheral nervous system. This review summarizes recent advances in the understanding of fate determination of neural crest cells into different glia subtypes, together with the potential implications in regenerative medicine.
    Cellular Signalling 12/2013; DOI:10.1016/j.cellsig.2013.12.007 · 4.32 Impact Factor
Show more